Pharma Equity Group A/S: Financial statements 2021
CVR: 26791413
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
Pharma Equity Group A/S (CVR 26791413) has filed annual accounts for 2021. In 2021, the company reported a net result of DKK 5,391,000 compared with DKK -32,875,000 the year before. Equity in the 2021 report amounted to DKK 42,566,000. The solvency ratio was 66.9%.
- Profit/Loss
- DKK 5,391,000
- Equity
- DKK 42,566,000
- Total Assets
- DKK 63,645,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | - | 5.4 mio. | 42.6 mio. | - |
| 2020 | - | - | -32.9 mio. | 34.3 mio. | - |
| 2019 | - | - | -14.4 mio. | 67.2 mio. | - |
| 2018 | - | - | -7.7 mio. | 77.6 mio. | - |
| 2017 | - | - | -4.1 mio. | 103.3 mio. | - |
Official annual report
Find more companies like Pharma Equity Group A/S
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2021
Pharma Equity Group A/S has published its interim report for the period January 1, 2021 – June 30, 2021.
Pharma Equity Group A/S has published its annual report for 2020. The net result was DKK -32,875,000.
Pharma Equity Group A/S has published its annual report for 2019. The net result was DKK -14,417,000.
About Pharma Equity Group A/S
Pharma Equity Group A/S is a Danish company of the type Aktieselskab based in Hørsholm, founded in 2002. The company is registered under the industry Investering for egen regning. The company was previously named BLUE VISION A/S and GUDME RAASCHOU VISION A/S. The management consists of Christian Henrik Tange. The board consists of Christian Vinding Thomsen (chair), Charlotte Pahl, Lars Rosenkrantz Gundorph and Omar Siraj M Qandeel. The company's owners include NIELS ERIK JESPERSEN HOLDING ApS, Beier Holding ApS and FINANSMANAGEMENT ApS. The company has 1 employee (2025). In 2025, the company reported a gross profit of DKK 0. Equity in the 2025 report amounted to DKK 25,472,000.